Holen Sie sich die Stockscreener-App
27.81
0.32%
-0.09
Handel nachbörslich:
27.50
-0.31
-1.11%
Schlusskurs vom Vortag:
$27.90
Offen:
$27.78
24-Stunden-Volumen:
2.11M
Relative Volume:
0.49
Marktkapitalisierung:
$1.73B
Einnahmen:
$14.34M
Nettoeinkommen (Verlust:
$-199.00M
KGV:
-7.0944
EPS:
-3.92
Netto-Cashflow:
$-183.51M
1W Leistung:
-6.93%
1M Leistung:
-55.91%
6M Leistung:
+79.42%
1J Leistung:
+375.79%
1-Tages-Spanne:
$26.20
$28.71
1-Wochen-Bereich:
$26.20
$31.38
52-Wochen-Spanne:
$5.705
$71.50
Uniqure N V Stock (QURE) Company Profile
Firmenname
Uniqure N V
Sektor
Branche
Telefon
1-339-970-7000
Adresse
PAASHEUVELWEG 25A, AMSTERDAM
Vergleichen Sie QURE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QURE
Uniqure N V
|
27.81 | 1.74B | 14.34M | -199.00M | -183.51M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Uniqure N V Stock (QURE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-04 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-08-14 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-04-01 | Fortgesetzt | Chardan Capital Markets | Buy |
| 2024-12-10 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-10-10 | Fortgesetzt | Raymond James | Outperform |
| 2024-02-29 | Herabstufung | Goldman | Buy → Neutral |
| 2023-12-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-03-17 | Hochstufung | UBS | Neutral → Buy |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-05-21 | Eingeleitet | UBS | Neutral |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-01-07 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-11-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-11 | Eingeleitet | Berenberg | Buy |
| 2020-11-09 | Eingeleitet | Jefferies | Buy |
| 2020-11-04 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-08-25 | Eingeleitet | Raymond James | Strong Buy |
| 2020-07-31 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-06-25 | Herabstufung | Mizuho | Buy → Neutral |
| 2020-06-25 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-06-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2019-12-03 | Eingeleitet | Cowen | Outperform |
| 2019-12-03 | Eingeleitet | Goldman | Buy |
| 2019-11-05 | Eingeleitet | Credit Suisse | Outperform |
| 2019-10-11 | Eingeleitet | Stifel | Buy |
| 2019-09-25 | Eingeleitet | Bernstein | Outperform |
| 2019-09-12 | Eingeleitet | Mizuho | Buy |
| 2019-07-30 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-07-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2019-04-12 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-03-29 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Uniqure N V Aktie (QURE) Neueste Nachrichten
Why uniQure N.V. (UQ1) stock is trending on social mediaJuly 2025 Breakouts & AI Optimized Trade Strategies - newser.com
uniQure NV Faces Weak Start with 5.08% Gap Down Amid Market Concerns - Markets Mojo
How currency fluctuations impact uniQure N.V. stock - newser.com
Is uniQure N.V. stock a buy on dipsTrade Analysis Report & Daily Volume Surge Signals - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of uniQure N.V.QURE - PR Newswire
Will uniQure N.V. stock deliver shareholder valueJuly 2025 Price Swings & Reliable Breakout Forecasts - newser.com
Is uniQure N.V. (UQ1) stock supported by strong fundamentals - newser.com
Reviewing uniQure (NASDAQ:QURE) and Biogen (NASDAQ:BIIB) - Defense World
Published on: 2025-11-19 17:01:52 - newser.com
Can uniQure N.V. stock hit record highs againTrade Volume Summary & Risk Controlled Stock Pick Alerts - newser.com
Predicting uniQure N.V. trend using moving averagesJuly 2025 PreEarnings & Reliable Intraday Trade Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against uniQure N.V. (QURE) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
uniQure N.V. (QURE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - FinancialContent
Wall Street Has a Positive Outlook on uniQure N.V. (QURE) Despite Challenges From The FDA - MSN
Summers Value Partners Established a Position in UniQure N.V. (QURE) in Q3 - Insider Monkey
Can uniQure N.V. (UQ1) stock sustain revenue momentumQuarterly Earnings Summary & Detailed Earnings Play Strategies - newser.com
Can uniQure N.V. stock hit analyst price targetsTrade Risk Report & Safe Entry Point Identification - newser.com
Volatility clustering patterns for uniQure N.V.Gold Moves & Real-Time Chart Breakout Alerts - newser.com
Is uniQure N.V. stock a bargain at current levelsPortfolio Performance Report & Daily Volume Surge Signals - newser.com
uniQure NV Faces Weak Start with 10.32% Gap Down Amid Market Concerns - Markets Mojo
uniQure N.V. Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - FinancialContent
Do Rising Losses at uniQure (QURE) Reflect Strategic Investment or Escalating Cost Pressure? - simplywall.st
Hemophilia B Research Report 2025-2035: Market Led by UniQure, Pfizer, Novo Nordisk, HEMA Biologics, and Alnylam Pharmaceuticals as Next-Generation Therapies and R&D Investment Drive Innovation - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating uniQure N.V. (QURE) And Encourages Shareholders to Connect - ACCESS Newswire
How uniQure N.V. stock reacts to job market dataWeekly Risk Summary & Scalable Portfolio Growth Methods - newser.com
Ready to Jump After Recent Trade: uniQure N.V (QURE) - Setenews
What data driven models say about uniQure N.V.’s futureQuarterly Trade Report & Expert Verified Stock Movement Alerts - newser.com
How to read the order book for uniQure N.V.2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Risk adjusted return profile for uniQure N.V. analyzedJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
uniQure N.V. Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - FinancialContent
uniQure NV Hits Day High with 15.18% Surge Amid Market Volatility - Markets Mojo
Finanzdaten der Uniqure N V-Aktie (QURE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Uniqure N V-Aktie (QURE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gut Robert | Director |
Nov 06 '25 |
Sale |
27.26 |
31,434 |
856,881 |
40,145 |
| Kaye Jack | Director |
Nov 04 '25 |
Option Exercise |
9.88 |
38,810 |
383,535 |
38,249 |
| Kaye Jack | Director |
Nov 04 '25 |
Sale |
30.34 |
38,810 |
1,177,517 |
20,439 |
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):